Consolidated Statement of Cash Flows - USD ($) $ in Thousands		6 Months Ended
		Jun. 30, 2025	Jun. 30, 2024
Cash flows from operating activities:
Net loss		$ (11,148)	$ (33,985)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation		640	607
Amortization of intangible assets		5,421	5,421
Amortization of premium/discount on investments		0	(482)
Amortization of debt discount and debt issuance costs		1,664	1,380
Amortization of operating right-of-use assets		246	340
Deferred income tax expense (benefit)		0	1,056
Stock-based compensation		9,451	8,000
Change in fair value of contingent value rights		0	(3,968)
Changes in operating assets and liabilities:
Trade accounts receivable		(12,633)	(3,243)
Prepaid expenses and other current assets		1,803	(1,577)
Inventory		(11,190)	(4,597)
Accounts payable		(367)	(6,063)
Other accrued liabilities		(3,230)	442
Accrued trade discounts and rebates		8,445	1,126
Accrued returns reserve		700	1,999
Operating lease liabilities		(742)	1,064
Other		1,091	1,829
Net cash used in operating activities		(9,849)	(30,651)
Cash flows from investing activities:
Capital expenditures		(292)	(561)
Purchases of investments		0	(29,486)
Sales and maturities of investments		0	15,000
Net cash used in investing activities		(292)	(15,047)
Cash flows from financing activities:
Proceeds from debt refinancing		0	50,000
Proceeds from issuance of employee stock purchase plan shares		830	710
Payment of debt discount		0	(11,831)
Proceeds from exercise of stock options		5,833	459
Repurchase of common stock withheld for taxes		(8,858)	(3,485)
Net cash provided by (used in) financing activities		(2,195)	35,853
Decrease in cash, cash equivalents and restricted cash		(12,336)	(9,845)
Cash, cash equivalents and restricted cash, beginning of quarter		75,744	71,674
Cash, cash equivalents and restricted cash, end of quarter		63,408	61,829
Supplemental schedule of cash flow information:
Cash paid for interest		13,090	8,320
Supplemental schedule of non-cash activities:
Issuance of common shares in settlement of CVR liability		0	15,803
Exercise of stock options		279	0
Issuance of common shares in partial settlement of 2025 Convertible Debt		15,146	0
Cash flows from operating activities:
Cash and cash equivalents		59,285	57,604
Restricted cash included in Other assets (1)	[1]	4,123	4,225
Total cash, cash equivalents and restricted cash shown in the consolidated statements of cash flows		$ 63,408	$ 61,829

[1] These restricted cash items are primarily security deposits in the form of letters of credit for the Company to secure certain leases.